4.4 Article

The effectiveness of national guidance in changing analgesic prescribing in primary care from 2002 to 2009: An observational database study

期刊

EUROPEAN JOURNAL OF PAIN
卷 17, 期 3, 页码 434-443

出版社

WILEY
DOI: 10.1002/j.1532-2149.2012.00189.x

关键词

-

资金

  1. NIHR School for Primary Care Research
  2. North Staffordshire Primary Care Research Consortium
  3. National Coordinating Centre for Research Capacity Development (NCCRCD)
  4. National Institute for Health Research [RP-PG-0407-10386] Funding Source: researchfish
  5. National Institutes of Health Research (NIHR) [RP-PG-0407-10386] Funding Source: National Institutes of Health Research (NIHR)

向作者/读者索取更多资源

Background Numerous national guidelines have been issued to assist general practitioners' safe analgesic prescribing. Their effectiveness is unclear. The objective of this study was to examine trends in general practitioners' prescribing behaviour in relation to national guidelines. Methods This was a retrospective observational database study of registered adult patients prescribed an analgesic (20022009) from the Consultations in Primary Care Archive 12 North Staffordshire general practices. Prescribing guidance from the UK Medicines Regulatory Health Authority (MHRA) regarding non-steroidal anti-inflammatory drugs (NSAIDs) and co-proxamol, and the National Institute for Health and Clinical Excellence (NICE) osteoarthritis (OA) management guidelines were considered. Analgesic prescribing rates were examined, arranged according to a classification of six equipotent medication groups: (1) basic analgesics; (2)(5) increasingly potent opioids and (6) NSAIDs. In each quarter from 2002 to 2009, the number of patients per 10,000 registered population receiving a prescription for the first time from each group was determined. Quarters associated with significant changes in the underlying prescribing trend were determined using joinpoint regression. Results A significant decrease in incident co-proxamol and Cox-2 prescribing occurred around the time of the first MHRA advice to stop using them and were rarely prescribed thereafter. The new prescribing of weak analgesics (e.g., co-codamol 8/500) increased at this same time. Initiating topical NSAIDs significantly increased around the time of the NICE OA guidelines. Conclusions Significant prescribing changes occurred when national advice and guidelines were issued. The effectiveness of this advice may vary depending upon the content and method of dissemination. Further evaluation of the optimal methods for delivering prescribing guidance is required.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据